CJC-1295 without DAC (Modified GRF 1-29) is a short-acting growth hormone-releasing peptide that mimics natural growth hormone-releasing hormone (GHRH) to stimulate growth hormone (GH) pulses, requiring frequent dosing (daily/twice daily) due to its rapid clearance (half-life ~30 min-2 hrs). It’s used in research to study GH release, supporting muscle growth, fat loss, and recovery, often combined with Ipamorelin for enhanced effects, and is known for mimicking the body’s natural GH rhythms without the long-lasting side effects of the DAC versionDescription
🧬 CJC-1295 (Without DAC) – 5mg
🧬 CJC-1295 (Without DAC) – 5mgCJC-1295 (without DAC), also known as Modified GRF 1-29, is a synthetic research peptide designed to mimic endogenous growth hormone–releasing hormone (GHRH). Unlike the DAC-modified version, this peptide exhibits a short half-life, making it suitable for studies involving pulsatile hormone signaling.
In laboratory and experimental settings, CJC-1295 (No DAC) is widely investigated for its interaction with GHRH receptors and its role in regulated growth hormone release models. Its rapid clearance profile allows researchers to study natural GH rhythm dynamics without prolonged receptor stimulation.
Research applications often include:
-
Growth hormone release signaling studies
-
GHRH receptor activation research
-
Pulsatile endocrine signaling models
-
Hormone rhythm and feedback mechanism analysis
Manufactured to high purity standards, this peptide is supplied as a lyophilized powder to ensure stability and accuracy in laboratory research environments.
CJC-1295 (Without DAC) from Johnson Peptides is intended exclusively for laboratory research and scientific investigation.
Available Variation
-
5mg
Product Specifications
-
Peptide Type: GHRH Analog Research Peptide
-
DAC: None
-
Form: Lyophilized Powder
-
Purity: ≥99% (HPLC verified)
